Form 4: Tyra Biosciences Director Nina S. Kjellson Sells Shares

Director Nina S. Kjellson of Tyra Biosciences sold a portion of her holdings in common stock through indirect ownership.

Summary

• Nina S. Kjellson, a director at Tyra Biosciences, has sold shares of common stock.
• The sales occurred on November 25, 2024.
• A total of 4,706 shares were sold at a weighted average price of $16.8386 per share through Canaan XI L.P.
• An additional 566 shares were sold at the same weighted average price through 2020+ Co-Investment L.P. Series 7.
• The shares were sold in multiple transactions with prices ranging from $16.75 to $16.95.
• Following these transactions, Kjellson indirectly owns 3,731,165 shares through Canaan XI L.P. and 448,692 shares through 2020+ Co-Investment L.P. Series 7.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of insider trading activity, which is neither positive nor negative in itself. The sentiment is neutral.

Risks

• Sales by insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

Insider trading activity is a common occurrence in the stock market, and this transaction is a routine disclosure of a director's stock sale.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting insider transactions in publicly traded companies.
• The sale of shares by a director is not unusual and is often part of personal financial planning or portfolio management.
• The transaction is similar to other insider sales reported by directors and officers of publicly listed companies.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment.

Key Dates

Keywords

Tyra Biosciences, insider trading, stock sale, Nina S. Kjellson, Canaan XI L.P., 2020+ Co-Investment L.P., common stock, director